Kyverna Therapeutics (KYTX) Q4 2024 Earnings

13NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-20.54
-13.91
-7.29
-0.67

Details

Expected EPS
-0.814276
Actual EPS
-0.8
Surprise EPS
0.01
Surprise Percent
+1.75%

Description

Kyverna Therapeutics (KYTX) has reported earnings of -0.8 per share for Q4 2024.

0 Comments

Share your thoughts